HGYMF (Hogy Medical Co) EBIT: $8.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HGYMF Hogy Medical Co Ltd HGYMF
57 GF Score
Price $34.99
GF Value $23.24
! 10 Warning Signs
View Full Analysis

What is Hogy Medical Co EBIT?

Hogy Medical Co HGYMF 57 EBIT is $8.0 Mil as of Dec. 2025. GuruFocus rates HGYMF with a GF Score™ of 57/100 and a GF Value™ of $23.24. The stock has 10 warning signs investors should review.

Hogy Medical Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was $4.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $8.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hogy Medical Co's annualized ROC % for the quarter that ended in Dec. 2025 was 3.20%. Hogy Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hogy Medical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.91%.


Hogy Medical Co  (OTCPK:HGYMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hogy Medical Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=20.808 * ( 1 - 27.98% )/( (474.621 + 463.169)/ 2 )
=14.9859216/468.895
=3.20 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=605.984 - 25.546 - ( 117.269 - max(0, 50.168 - 267.973+117.269))
=463.169

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Hogy Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=19.548/( ( (301.076 + max(67.169, 0)) + (282.025 + max(79.197, 0)) )/ 2 )
=19.548/( ( 368.245 + 361.222 )/ 2 )
=19.548/364.7335
=5.36 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(44.724 + 67.157 + 5.078) - (30.15 + 0 + 19.64)
=67.169

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(48.077 + 60.43 + 8.037) - (25.546 + 0 + 11.801)
=79.197

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hogy Medical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=7.972/871.669
=0.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hogy Medical Co EBIT Related Terms


Hogy Medical Co EBIT Historical Data

* Premium members only.

The historical data trend for Hogy Medical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hogy Medical Co EBIT Chart

Hogy Medical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.32 53.06 46.52 27.35 20.15

Hogy Medical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.14 -5.85 7.13 1.81 4.89

HGYMF vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Hogy Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hogy Medical Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hogy Medical Co's EV-to-EBIT falls into.


HGYMF
57GF Score
Hogy Medical Co Ltd HGYMF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hogy Medical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $8.0 Mil mean?
Hogy Medical Co (HGYMF) has a EBIT of $8.0 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hogy Medical Co.
Is Hogy Medical Co's EBIT too high?
Hogy Medical Co's current EBIT is $8.0 Mil. Overall, Hogy Medical Co has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's EBIT compare to ISRG and BDX?
Hogy Medical Co's EBIT of $8.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Hogy Medical Co. Hogy Medical Co's current EBIT is $8.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Hogy Medical Co (HGYMF) has a current EBIT of $8.0 Mil. The stock's GF Value™ is $23.24, compared to a current price of $34.99 — trading 50.6% above its estimated fair value. The current EBIT is $8.0 Mil. Hogy Medical Co's overall GF Score™ is 57/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Hogy Medical Co (HGYMF), the current EBIT is $8.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hogy Medical Co (HGYMF) Overvalued in 2026?

Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued. The current stock price of $34.99 is trading 50.6% above its estimated GF Value™ of $23.24.

Key valuation signals for HGYMF:

  • EBIT: $8.0 Mil
  • GF Value™: $23.24 vs. price of $34.99 (50.6% above fair value)
  • GF Score™: 57/100 with 10 warning signs

No single metric tells the full story. See the HGYMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hogy Medical Co Business Description

Address 7-7, Akasaka 2-chome, Minato-ku, Tokyo, JPN, 107-8615
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
57GF Score

Get the complete analysis for HGYMF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.99
Price
$23.24
GF Value